Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran

[1]  F. Mokarian,et al.  Specific TaqMan allelic discrimination assay for rs1477196 and rs9939609 single nucleotide polymorphisms of FTO gene demonstrated that there is no association between these SNPs and risk of breast cancer in Iranian women , 2015, Advanced biomedical research.

[2]  M. Noruzinia,et al.  DNA methylation as a promising landscape: A simple blood test for breast cancer prediction , 2015, Tumor Biology.

[3]  P. Mehdipour,et al.  Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients , 2015, Journal of Molecular Medicine.

[4]  Zhou Wang,et al.  PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma , 2015, Tumor Biology.

[5]  H. Chu,et al.  DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival , 2014, Breast Cancer Research.

[6]  M. Noruzinia,et al.  Epigenetic marks in estrogen receptor alpha CpG island correlate with some reproductive risk factors in breast cancer , 2014, Molecular Biology Reports.

[7]  C. Atalay.  Epigenetics in breast cancer. , 2013, Experimental oncology.

[8]  P. Lønning,et al.  Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors , 2013, BMC Cancer.

[9]  S. Fouladdel,et al.  The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines , 2013, Iranian journal of cancer prevention.

[10]  Xiao-bin Cui,et al.  Analysis of PTEN Methylation Patterns in Soft Tissue Sarcomas by MassARRAY Spectrometry , 2013, PloS one.

[11]  Hong-Yan Zhang,et al.  PTEN mutation, methylation and expression in breast cancer patients , 2013, Oncology letters.

[12]  Katarzyna Lubecka-Pietruszewska,et al.  Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. , 2013, Biochemical and biophysical research communications.

[13]  M. Kazemi,et al.  Study of promoter methylation pattern of 14-3-3 sigma gene in normal and cancerous tissue of breast: A potential biomarker for detection of breast cancer in patients , 2012, Advanced biomedical research.

[14]  M. Karimipoor,et al.  Promoter Hypermethylation of Estrogen Receptor Alpha Gene Is Correlated to Estrogen Receptor Negativity in Iranian Patients with Sporadic Breast Cancer , 2012, Cell journal.

[15]  Sung-Chul Lim,et al.  Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells , 2011, Breast Cancer Research and Treatment.

[16]  Tavassoli Manoochehr,et al.  Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation , 2011, Medical oncology.

[17]  P. Mehdipour,et al.  The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer , 2010, Cancer Causes & Control.

[18]  V. Kristensen,et al.  The epigenetics of breast cancer , 2010, Molecular oncology.

[19]  T. Sørlie,et al.  Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer , 2010, Breast Cancer Research.

[20]  Takashi Kumagai,et al.  PTEN promoter is methylated in a proportion of invasive breast cancers , 2004, International journal of cancer.

[21]  Mariano Provencio,et al.  Promoter methylation of the PTEN gene is a common molecular change in breast cancer , 2004, Genes, chromosomes & cancer.

[22]  M. Turker.  Gene silencing in mammalian cells and the spread of DNA methylation , 2002, Oncogene.

[23]  Li Mao,et al.  Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  J. Herman,et al.  Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. , 2000, Journal of the National Cancer Institute.

[25]  Z. Rahimi,et al.  Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[26]  Z. Rahimi,et al.  Matrix Metalloproteinase-9-1562 T Allele and its Combination with MMP-2-735 C Allele are Risk Factors for Breast Cancer , 2015 .

[27]  Z. Rahimi,et al.  The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[28]  X. Shu,et al.  Emerging role of PR domain containing 5 (PRDM5) as a broad tumor suppressor in human cancers , 2014, Tumor Biology.

[29]  F. Luft.  C/EBPβ LIP induces a tumor menagerie making it an oncogene , 2014, Journal of Molecular Medicine.

[30]  M. Taheri,et al.  Association of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndrome. , 2013, Molecular medicine reports.

[31]  J. Herman,et al.  Methylation-specific PCR. , 2009, Methods in molecular biology.